Precision medicine

Precision medicine aims to alter the treatments based on individual characteristics, including differences in genetics, environment, and lifestyle.

Today, the University of Oxford, Prenetics Limited, a global leader in diagnostics and genetic testing, and Oxford Suzhou Centre for Advanced Research (OSCAR) have signed collaboration agreements to further develop the award-winning OxLAMPTM technology, a rapid, molecular testing technology for infectious diseases.

Meet 35 people whose ideas will shape the future.

Latest illustration for Columbia Medicine magazine about how the growing use of precision medicine's exome sequencing provides potential for happy endings in treating severe childhood illnesses....

Many of these opportunities and challenges (for pharmacogenomics) pertain to infrastructure, study design, policy, and science culture in the early 21st century. Ultimately, rational pharmacogenomics study design and the acquisition of comprehensive phenotypic data that proportionately match the genomics data be an imperative as we move forward toward global precision medicine.

To develop precision medicine, the need to identify various disease stages of the patients is facilitated by biomarkers. In this new era, biomarkers are mostly focused on genetics, specifically, they are molecules or genes or hormones.

Read sample

Precision medicine is changing the way therapies are being developed. It has widespread implications for everything from genomics to medical devices, and creates new models for enterprises.